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Characterization of uropathogenic Escherichia coli strains
obtained from urology outpatient clinic of Ege Medical Faculty
in İzmir
Betül GİRAY1, Füsun Bahriye UÇAR1, Sabire Şöhret AYDEMİR2

Aim: To identify the papG gene and its allelic variation in uropathogenic Escherichia coli (UPEC) strains isolated from
patients with acute pyelonephritis and cystitis.
Materials and methods: Seventy-five E. coli strains isolated from patients admitted to the University of Ege Medical
Faculty urology outpatient clinic were isolated and identified phenotypically. All of these strains were examined for the
papG gene and allelic distribution of this gene with the multiplex polymerase chain reaction technique.
Results: papG genes were found in 24 of 75 E. coli strains. Of these 24 strains, 7 (29%) had papG class II only, 8 (33%)
had class III only, and 9 (38%) had both class II and III. Phylogenetically, it was found that 31 belonged to group B2,
19 to group D, 20 to group A, and 5 to group B1. Serotyping was performed and thepositivity was found to be 39%.
When the antibiotic resistance profiles of the 75 strains were evaluated, 41 (55%) of them were found to be resistant to
ampicillin, 35 (47%) to ciprofloxacin, and 35 (47%) to trimethoprim/sulfamethoxazole. In addition, 23 strains (31%)
produced extended-spectrum beta-lactamase.
Conclusion: In this study, the rate of papG-positive strains was found to be low. However, there is no consensus on the
molecular definition of UPEC. Although the presence of the papG gene indicates that the strains are UPEC, absence of
the papG gene does not suggest that the strains are not UPEC.
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Introduction
Urinary tract infections (UTIs) are among the most
common infections that affect humans (1,2). Fifty
percent of all women will experience at least 1 UTI
in their lifetime and, of those, about 25% will have
1 or more recurrent infections (3,4). In 90% of
uncomplicated UTIs, the most common bacterium
is Escherichia coli (2,5). E. coli strains causing
disease outside the gastrointestinal tract have been
named extraintestinal pathogenic E. coli (ExPEC)
(6), and among the ExPEC, uropathogenic E. coli

(UPEC) is the most common pathogen in humans
(7). UPEC strains are characterized with specific
virulence factors closely related with colonization
and persistence of bacteria in the urinary tract.
These factors include adhesins or fimbriae,
siderophore systems, and toxins. For the initiation
of UTI, colonization of UPEC is required. Therefore,
colonization and adhesion to host tissues is crucial
for UPEC pathogenesis. At this stage, expression
of the P-fimbriae frequently present in UPEC, and
especially in UPEC strains isolated from patients
with pyelonephritis, is extremely important (8,9). So
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far, P-fimbriae have been detected in the majority of
patients with acute pyelonephritis and cystitis who
have a normal immune system (10,11). G adhesin,
located at the tip of P-fimbriae and encoded by the
pap operon, contributes to the progress of the disease
by binding to specific receptors in the uroepithelial
cells (8,12).
Depending on receptor specificity, papG adhesin
has 3 different variants (Class I to Class III), and in
studies conducted to date it has been proposed that
there is a relationship between the specific alleles of
genes encoding G adhesin and various forms of the
disease (10,12,13).
Phylogenetic analyses by multilocus enzyme
electrophoresis have shown that E. coli strains fall
into 4 main phylogenetic groups: A, B1, B2, and D.
While nonpathogenic E. coli strains are typically from
phylogenetic groups A and B1, ExPEC, particularly
UPEC strains, frequently are members of group B2 or
group D and often exhibit specific O:K:H serotypes
(14–16).
The aim of this study was to detect papG alleles
and to define the distribution of 3 papG alleles among
E. coli isolates from 75 patients with acute cystitis and
pyelonephritis at a hospital in İzmir, and to investigate
the link between phylogeny and virulence factors.
Materials and methods
Bacterial strains
Seventy-five E. coli strains were isolated from the
urine cultures of patients with acute cystitis and
acute pyelonephritis that presented to the University
of Ege Medical Faculty urology outpatient clinic
between January and April 2010. Identification of
these strains was performed biochemically with the
VITEK 2 Compact System (bioMérieux, France) in
the hospital. Reference E. coli strains J96 (papGI and
III), 2H16 (papG II), K12 (negative control for papG,
positive control for uidA), EcoR20 (A), EcoR48 (D),
EcoR58 (B1), and EcoR62 (B2) were kindly provided
by J. R. Johnson (University of Minnesota) and used
as control strains. E. coli ATCC 25922 was used as
a quality control strain for antibiotic susceptibility
testing. Strains were stored at –30 °C in tryptic soy
broth with 20% glycerol until they were used.

The ethical committee approval date was
16.11.2009 and the decision number was 09/11.1/10.
Serotyping
Isolated E. coli strains were serotyped with polyvalent
antisera (O Pool 8 ExPEC, Statens Serum Institut
SSI Diagnostica, Denmark) for ExPEC strains
including O1, O2, O4, O6, O7, O15, O18ac, and
O75 serotypes. The assay was performed according
to the manufacturer’s instructions. E. coli strain J96
serotype O4:K6 was used for positive control.
Antimicrobial susceptibility testing
In vitro susceptibility of E. coli strains was determined
with the disk diffusion method according to Clinical
and Laboratory Standards Institute guidelines
(17), and then the following drugs were tested:
cephalothin (30 mg), imipenem (10 mg), cefotaxime
(30 mg), cefepime (30 mg), ciprofloxacin (5 mg),
ampicillin (10 mg), aztreonam (30 mg), ceftazidime
(30 mg), amikacin (30 mg), meropenem (10 mg),
ampicillin/sulbactam (20 mg), cefuroxime (30
mg), piperacillin/tazobactam (110 mg), gentamicin
(10 mg), amoxicillin/clavulanic acid (30 mg), and
trimethoprim/sulfamethoxazole (25 mg) (Oxoid,
UK). Extended-spectrum beta-lactamase (ESBL)
production was detected using the double-disk
synergy (DDS) test in our laboratory (18). Similarly,
the antimicrobial susceptibility test and ESBL
production were performed with the VITEK 2
Compact System in the hospital.
DNA extraction, uidA gene detection, and
phylogenetic analysis
DNA extraction was carried out with the rapid
minipreparation procedure (19). The 75 E.
coli isolates were tested for the uidA gene with
appropriate primers by conventional polymerase
chain reaction (PCR) (J. R. Johnson, 2010, personal
communication). Phylogenetic grouping of all
isolates was determined by a modified version of the
multiplex PCR method as described previously (15).
As distinct from the method used by Clermont et al.
(15), we used different TSPE4C.2 primers (20). The
primer sequences, the size of the amplified fragment
(base pair), and the annealing temperature are
shown in Table 1. The conventional and multiplex
PCRs were performed using the NanoHelix PCR kit
(HelixAmp™Taq DNA polymerase, NanoHelix Co.,
1329

Identification and characterization of uropathogenic E. coli

Table 1. List of the primers used in the study.
Genes
UidA
papG I
papG II and III
papG class I
papG class II
papG class III
chuA
Yja
TSPE4.C2

Primer sequence (5’-3’)

Primer name

F GCGTCTGTTGACTGG CAG GTGGTG G

uidAF

R GTTGCCCGCTTCGAAACCAATGCC T

uidAR

F CTGTAATTACGGAAGTGATTTCTG

pGf

R TCC AGA AATAGCTCATGTAACCCG

PG 1r

F CTGTAATTACGGAAGTGATTTCTG

pGf

R ACT ATCCGG CTC CGG ATA AAC CAT

pGr

F CAACCTGCT CTC AATCTTTAC TG

PF1

R CAT GGCTGGTTGTTC CTA AAC AT

PF1,3

F GGAATGTGGTGATTA CTC AAA GG

PF2

R TCC AGA GACTGTGCAGAAGGA C

PF2,3

F CAT GGCTGGTTGTTC CTA AAC AT

PF1,3

R TCC AGA GACTGTGCAGAAGGA C

PF2,3

F GACGAACCAACGGTCAGG AT

ChuA.1

R TGCCGC CAG TACCAA AGA CA

ChuA.2

F TGAAGTGTCAGG AGA CGC TG

YjaA.1

R ATG GAG AATGCGTTC CTC AAC

YjaA.2

F AGTAATGTCGGGGCATTC AG

TSPE4.CII’ F

R TCGCGCCAACAAAGT ATT ACG

TSPE4.CII’R

Size of product (bp)

Source of primer

508 bp

Johnson, PC, 2010

1190 bp

21

1070 bp

21

692 bp

10

562 bp

10

421 bp

10

279 bp

15

211 bp

15

151 bp

20

PC: personal communication; F: forward primer; R: reverse primer.

Ltd., South Korea). These assays were carried out
according to the manufacturer’s instructions.
Detection of the papG gene and allelic variation
To investigate the presence of the papG gene and its
allelic variation, we used flanking and internal allelespecific papG primers (Table 1). First, papG was
detected by multiplex PCR with flanking primers as
previously described (21). papG-positive strains were
then investigated in terms of allelic variation. For
this, 3 papG classes were determined by multiplex
PCR with internal primers (Table 1) as previously
described (10), but this method was modified. For
this purpose, we used a Hot Start PCR kit (i-StartTaq™
DNA polymerase, iNtRON Biotechnology, South
Korea) and the assay was performed in a total volume
20 µL of mixture containing 2 µL PCR buffer, 2 µL
dNTP, 0.2 µL DNA polymerase, 2 µL template DNA,
7 pmol PF2 and PF2,3, and 10 pmol PF1 and P1,3.
1330

PCR parameters were as follows: 2 min at 94 °C; 30
cycles of 20 s at 94 °C, 10 s at 63 °C, and 40 s at 72 °C;
and final extension of 5 min at 72 °C.
Products of conventional and multiplex PCRs
were electrophoresed in 1.5% and 2% agarose gel
with 0.5 µg/mL ethidium bromide, respectively.
Gels were photographed by using an ultraviolet
transilluminator and digital capture system (DNr BioImaging Systems Ltd., Israel). The size of amplicons
was determined by comparing them with a 100-bp
DNA ladder (ABM Inc., Canada).
Statistical analysis
The associations between phylogeny and
antimicrobial susceptibility results were tested using
Fisher’s exact test (2-tailed). SPSS 11.0 for Windows
(SPSS Inc., USA) was used in the study. α = 0.05 was
used for all analysis.
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Results
Presence of uidA gene, serotyping, and phylogenetic
analysis
The 75 E. coli isolates were categorized for the presence
of the uidA gene, serogroup, and phylogenetic status
as listed in Table 2; 73 (97%) of the 75 E. coli strains
were found positive for the uidA gene (Figure 1).

Our strains were tested with polyvalent antisera,
and of the 75 strains, 29 (39%) were serotyped as
positive and 46 (61%) were negative.
Phylogenetic grouping was determined as
described by Clermont et al. (15) and was as follows:
31 (41%) strains belonged to group B2, 19 (25%)
belonged to group D, 20 (27%) belonged to A, and 5
(7%) belonged to B1 (Figure 2).

Table 2. List of 75 E. coli isolates with clinical data, serotyping, uidA gene, and phylogenetic status.
Identification
Serotyping
code
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-

Clinical
data
Pyelonephritis
Cystitis
Cystitis
Pyelonephritis
Pyelonephritis
Pyelonephritis
Pyelonephritis
Cystitis
Cystitis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Pyelonephritis
Pyelonephritis
Pyelonephritis
Cystitis
Pyelonephritis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Cystitis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Pyelonephritis
Pyelonephritis

uidA
gene

Phylogenetic
status

Identification
code

Serotyping

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

D
B2
B2
B2
A
A
A
A
D
A
A
B1
D
A
A
B2
B2
B1
D
B2
B2
D
D
B2
B1
D
B2
B2
B2
D
B2
A
D
B2
D
A
B2
D

39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75

+
+
+
+
+
+
+
+
+
-

Clinical
data
Pyelonephritis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Cystitis
Pyelonephritis
Pyelonephritis
Pyelonephritis
Pyelonephritis
Cystitis
Pyelonephritis
Pyelonephritis
Pyelonephritis
Cystitis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Pyelonephritis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Pyelonephritis
Cystitis
Cystitis
Pyelonephritis
Cystitis
Pyelonephritis
Cystitis

uidA
gene

Phylogenetic
status

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

B2
B2
B2
B2
A
B2
D
D
A
A
D
B2
A
A
B2
B2
A
B2
B2
D
B1
D
D
B2
A
A
D
B1
A
D
B2
B2
B2
B2
A
B2
B2
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Figure 1. Presence of the uidA gene in 25 E. coli strains. Line 1: marker (M); line 2:
positive control (K12); line 3: negative control (NK); lines 4–16: E. coli strains;
line 17: marker (M); lines 18-29: E. coli strains (data for other strains not
shown).

Figure 2. Phylogenetic distribution of 23 E. coli isolates. Line 1: marker (M); line 2:
E58; line 3: E48; line 4: E62; line 5: E20; lines 6–15: E. coli isolates (strains
numbered as 17, 21, 23, 24, 25, 27, 29, 35, 38, and 67); line 16: marker (M);
lines 17-29: E. coli strains (strains numbered as 43, 50, 53, 54, 12, 2, 11, 7, 3, 9,
36, 52, and 30) (data for other strains not shown).

Antimicrobial resistance
Of the 75 isolates, 41 (55%) were resistant to
ampicillin, 35 (47%) to ciprofloxacin, and 35 (47%)
to trimethoprim/sulfamethoxazole. In addition, 23
isolates (31%) were found to produce ESBL (Table 3).
Detection and distribution of papG alleles and
clinical correlation
papG was detected by PCR in 24 (32%) of the 75
strains (Figure 3). Seven (29%) strains had papG class
II only, 8 (33%) strains had class III only, and 9 (38%)
strains had both class II and III (Figure 4). When the
relationship between papG alleles and the diagnosis
was inspected, it was found that whereas of the 15
1332

patients with pyelonephritis, 5 had papG II, 5 had
papG III, and 5 had pap G II and III together, of the 9
patients with cystitis, 2 had papG II, 3 had papG III,
and 4 had papG II and III together (Table 4).
Association between phylogeny and antimicrobial
susceptibility
When the relationship between the phylogenetic
distribution of strains and ciprofloxacin and TMPSMX (which are widely used in treatment) was
inspected, most of the ciprofloxacin resistance (65%)
was observed in group A strains and TMP-SMX
resistance (63%) in group D strains, and these results
were not statistically significant.
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Table 3. Antibiotic resistance of E. coli isolates.
Antibiotic

Resistant (n (%))
(n = 75)

Ampicillin

41 (55)

Gentamicin

26 (35)

Amikacin

0

Amoxicillin/clavulanic acid

18 (24)

Ampicillin/sulbactam

16 (21)

Piperacillin/tazobactam

11 (15)

Cephalothin

27 (36)

Cefepime

22 (30)

Ceftriaxone

23 (31)

Ceftazidime

22 (29)

Cefuroxime

24 (32)

Ciprofloxacin

35 (47)

Trimethoprim/sulfamethoxazole

35 (47)

Imipenem

0

Meropenem

0

Aztreonam

25 (33)

ESBL

23 (31)

n: isolate number.

Of the 23 ESBL-positive strains, 12 (52%)
belonged to group B2, 7 (31%) to group A, and 4
(17%) to group D. ESBL production was not observed
in group B1 at all.
Discussion
In this study, 75 E. coli strains that lead to UTIs
were isolated from patients with pyelonephritis and
cystitis. Because the uidA gene is present in more
than 90% of E. coli strains (22,23), the presence of
the uidA gene was investigated as an identification
marker. The uidA gene was detected in 97% of our
isolates.
Strains isolated in this study were tested with
O pool 8 ExPEC polyvalent antisera. O antigens
generally seen in UPEC strains usually include O1,
O2, O4, O6, O7, O8, O15, O16, O18ac, O25, O50,
and O75 (24,25), but the antisera used in this study
did not include O8, O16, O25, or O50. In addition,
strains were not tested with monovalent antisera
specific to UPEC. Hence, the rate of positivity was
39%, and it was thought that this low positivity rate
was due to the fact that the polyvalent did not include
certain O antigens specific to UPEC strains, or that
strains included serological phenotypes specific to
other pathotypes.
In phylogenetic analyses performed to date, it has
been reported that ExPEC strains mostly belong to
group B2, followed by group D (15,16). As expected,
in our study, too, the most common phylogenetic
group in the UPEC isolates was B2.

Figure 3. Detection of the papG gene. Line 1: marker (M); line 2: J96 (positive control
for papG I and III); line 3: 2H16 (positive control for papG II); line 4: K12
(negative control for papG); line 5–16: papG-positive strains; line 17: marker
(M); lines 18-29: papG-positive isolates.
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Figure 4. Determination of papG alleles. A) Line 1: marker (M); line 2: J96 (positive
control for papG I and III); line 3: 2H16 (positive control for papG II); line
4: K12 (negative control for papG); lines 5–16: distribution of papG alleles in
papG-positive strains. B) Line 1: marker (M); lines 2–13: distribution of papG
alleles in papG-positive strains.
Table 4. Distribution of papG allele in papG-positive E. coli strains, clinical data, and phylogenetic status.
Identification
code
2
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Clinical data
Cystitis

papG class I
−

papG class II

papG class III

papG class II/III

Phylogenetic
status

−

+

−

B2

3

Cystitis

−

−

+

−

B2

7

Pyelonephritis

−

−

−

+

A

11

Cystitis

−

−

−

+

A

12

Pyelonephritis

−

−

−

+

B1

17

Pyelonephritis

−

+

−

−

B2

21

Pyelonephritis

−

+

−

−

B2

23

Cystitis

−

−

−

+

D

24

Cystitis

−

+

−

−

B2

25

Pyelonephritis

−

−

+

−

B1

27

Cystitis

−

−

+

−

B2

29

Pyelonephritis

−

−

+

−

B2

35

Pyelonephritis

−

−

−

+

D

38

Pyelonephritis

−

−

−

+

D

39

Pyelonephritis

−

−

−

+

B2

43

Cystitis

−

−

−

+

A

49

Pyelonephritis

−

+

−

−

D

50

Pyelonephritis

−

+

−

−

B2

53

Pyelonephritis

−

−

+

−

B2

54

Pyelonephritis

−

−

+

−

B2

56

Cystitis

−

−

−

+

B2

61

Pyelonephritis

−

+

−

−

D

68

Cystitis

−

+

−

−

D

74

Pyelonephritis

−

−

+

−

B2
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In studies performed to date, P-fimbriae have been
determined in E. coli strains isolated from the majority
of patients with UTI and urosepsis (1,10,11,13,26).
While the papG positivity rate was 76% in a study of
urosepsis patients (13) and 65% in another study of
patients with pyelonephritis and bacteremia (26), in
our study, the papG gene was identified in 24 (32%)
of the 75 E. coli strains isolated from 42 patients with
cystitis and 33 with pyelonephritis.
The fact that the papG gene was not detected in
the majority of the strains in this study does suggest
that these strains are not UPEC strains (Johnson,
2010, personal communication). Hence, the presence
of the papG gene alone cannot be regarded as an
adequate marker for the identification of UPEC at
the molecular level. The presence of this gene can
provide information about the level of infection if
it is associated with pyelonephritis. Therefore, other
virulence genes should be investigated for extensive
epidemiological studies.
When the allelic distribution of papG is
considered, only 7 strains had papG II and 8 strains
had papG III only, but papG II/III was observed at
a higher rate. In addition, when the relationship
between the diagnosis and papG alleles detected is
considered, no definite correlation was observed.
In other studies (10,13,26), while the papG II/III
combination of alleles was rarely observed, in our
study it was detected at a higher rate in patients with
cystitis and pyelonephritis. This is thought to result
from the diagnoses of urine samples of the patients
or from regional differences.
Picard et al. stated that there was a link between
virulence factors of phylogeny and extraintestinal
E. coli strains (14). According to their findings, the
pap operon was found in the strains of phylogenetic
groups D and B1, and most frequently in group B2.
Our results support these findings.
It is known that antibiotic susceptibility phenotypes
vary from one country to another or even from one
region to another. Indeed, in a study conducted by
İnan and Gürler in Turkey, ampicillin resistance was
determined in 68%, TMP-SMX resistance in 67%,
and amoxicillin-clavulanic acid resistance in 38%
of the patients who presented to outpatient clinics
(27). In another study, it was reported that of the E.
coli strains isolated from patients in the outpatient

clinic, 79% were resistant to ampicillin, 45% to TMPSMX, and 23% to ciprofloxacin (28). In our study,
the resistance rates to TMP-SMX and ciprofloxacin,
antibiotics widely used in empirical treatment, were
both 47%.
When the resistance rates to ampicillin,
trimethoprim/sulfamethoxazole, and ciprofloxacin,
which are the oral options for treatment, are
considered, ampicillin should not be used for empiric
treatment since the resistance rate to ampicillin
is above 50%. In addition, in Turkey, resistance to
TMP-SMX and ciprofloxacin has increased steadily
as antibiotics are widely used in treatment. Therefore,
today it is extremely important to conduct new
research on antibiotics and to detect the relationship
between bacterial virulence factors and the results
obtained from these studies.
In many studies conducted to date investigating the
relationship between antibiotics such as quinolones
(nalidixic acid, pipemidic acid), fluoroquinolones
(ciprofloxacin,
norfloxacin),
trimethoprim/
sulfamethoxazole,
beta-lactams
(ampicillin),
extended spectrum cephalosporins, and cephamycin
and bacterial virulence factors and phylogenetic
groups, it has been reported that organisms resistant
to these antibiotics belong to non-B2 groups and
contain virulence genes at a lower rate (29–31).
Relatedly, in this study, when the relationship
between papG and ciprofloxacin and trimethoprim/
sulfamethoxazole resistance was considered, it was
observed that of the 24 papG positive strains, 6
developed resistance to ciprofloxacin and 8 to TMPSMX. In the relationship between the phylogenetic
groups to which the phylogenetically grouped 75 E.
coli strains belong and resistance to ciprofloxacin and
TMP-SMX, no statistically significant correlation
was detected. However, the high resistance to TMPSMX observed in strains that phylogenetically
belong to group D suggests that these strains clonally
belong to group A or O15: K52: H1. In order to
reach a definitive diagnosis, additional tests are
needed (Johnson, 2012, personal communication).
In our study, in addition to these relationships, the
relationship between ESBL production and papG
was evaluated, and the papG gene was identified
only in 5 (22%) of the 23 strains that can produce
ESBL. These results support the argument that strains
whose antibiotic resistance is high have low virulence
1335
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factors. However, in this study, it was observed that
52% of the ESBL-producing strains belonged to
group B2. It is thought that ESBL strains belonging to
this group might be ST131 (Johnson, 2012, personal
communication).
There is a continuous fight between pathogenic
microorganisms and host cells in terms of attack
and defense mechanisms. In this fight, pathogenic
microorganisms defeat the host cells due to their
virulence factors and rapid evolution, and they
develop resistance to all kinds of treatment methods.
As can be seen in previous studies, since strains of
pathogenic microorganisms continuously acquire
new genes via horizontal gene transfer, continuous
changes occur in genes special to pathotypes.
Therefore, it is becoming more and more difficult
to reach a definitive diagnosis in distinguishing
pathotypes. The results of our research revealed that
there are not many studies conducted in Turkey on

E. coli pathotypes and uropathogenic E. coli. Studies
regarding these issues have usually focused on
antibiotic resistance. Therefore, in Turkey, detailed
studies should be performed especially on E. coli
pathotypes, virulence genes special to pathotypes
should be investigated, and comprehensive research
focusing on the production of new medicines
and vaccines that can overcome these virulence
mechanisms should be conducted.
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